Epidemiology of herpes zoster and its relationship to varicella in Japan: A 10-year survey of 48,388 herpes zoster cases in Miyazaki Prefecture

Journal of Medical Virology

Volumn 81, Issue 12, 2009, Pages 2053-2058

  Toyama, Nozomu ^a   Shiraki, Kimiyasu ^b   Amano, M ^c   Anegawa, S ^c   Aoki, Y ^c   Chousa, N ^c   Era, E ^c   Era, K ^c   Hachisuka, H ^c   Hidaka, M ^c   Hiejima, M ^c   Higashi, K ^c   Horinouchi, K ^c   Idemori, M ^c   Inoue, S ^c   Ishii, Y ^c   Ito, S ^c   Kanda, A ^c   Kaneda, R ^c   Kawai, S ^c   Kawana, N ^c   Kikuchi, I ^c   Kikuchi, T ^c   Kinoshita, M ^c   Kitamura, T ^c   Kohashi, M ^c   Koketu, H ^c   Kurokawa, M ^c   Kuroki, K ^c   Kuroki, Y ^c   Kuromizu, K ^c   Kuwahara, T ^c   Maeda, S ^c   Miyagi, T ^c   Miyakuni, H ^c   Miyazaki, Y ^c   Nagamine, H ^c   Nakano, H ^c   Nakano, S ^c   Nakayama, F ^c   Nakayama, K ^c   Narahara, S ^c   Narita, H ^c   Nishida, T ^c   Nobe, T ^c   Numata, T ^c   Oda, Y ^c   Ogata, K ^c   Oumaru, K ^c   Ohtsuka, K ^c   Okamura, H ^c   Sakaguchi, E ^c   Sakai, K ^c   Setoyama, M ^c   Tada, S ^c   Tajima, S ^c   Tajiri, A ^c   Takasaki, N ^c   Taketomi, I ^c   Tateyama, S ^c   Tazaki, T ^c   Teruya, N ^c   Tsumori, S ^c   Yamaguchi, K ^c   more..

^a Toyama Dermatology Clinic   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

^c NONE

Author keywords

Age; Epidemiology; Herpes zoster; Seasonal prevalence; Sex; Varicella

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHICKENPOX; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEALTH SURVEY; HERPES ZOSTER; HUMAN; INFANT; JAPAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OUTPATIENT DEPARTMENT; PREVALENCE; SCHOOL CHILD; SEASONAL VARIATION; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHICKENPOX; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGIC STUDIES; FEMALE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; INFANT; JAPAN; MALE; MIDDLE AGED; PREVALENCE; SEASONS; SEX FACTORS;

HERPES ZOSTER;

EID: 70350589248     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21599     Document Type: Article

References (26)

1. Anon. 2009. Varicella 1982-2004 (in Japanese). Infectious Agents Surveillance Report. The Topic of This Month 25: 318-320. http://idsc.nih.go.jp/ iasr/25/298/top298-jhtml.
2. Asano Y, Shiraki K, Takahashi M, Nagai H, Ozaki T, Yazaki T. 1981. Soluble skin test antigen of varicella-zoster virus prepared from the fluid of infected cultures. J Infect Dis 143:684-692. (Pubitemid 11122808)
3. Brisson M, Edmunds WJ. 2003. Epidemiology of varicella-zoster virus in England and Wales. J Med Virol 70:S9-S14. (Pubitemid 36368838)
4. Buchbinder SP, Katz MH, Hessol NA, Liu JY, O'Malley PM, Underwood R, Holmberg SD. 1992. Herpes zoster and human immunodeficiency virus infection. J Infect Dis 166:1153-1156.
5. Chapman RS, Cross KW, Fleming DM. 2003. The incidence of shingles and its implications for vaccination policy. Vaccine 21:2541-2547. (Pubitemid 36561347)
6. di Luzio Paparatti U, Arpinelli F, Visona G. 1999. Herpes zoster and its complications in Italy: An observational survey. J Infect 38:116-120. (Pubitemid 29229637)
7. Donahue JG, Choo PW, Manson JE, Platt R. 1995. The incidence of herpes zoster. Arch Intern Med 155:1605-1609.
8. Edmunds WJ, Brisson M, Rose JD. 2001. The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales. Vaccine 19:3076-3090. (Pubitemid 32324035)
9. Fleming DM, Cross KW, Cobb WA, Chapman RS. 2004. Gender difference in the incidence of shingles. Epidemiol Infect 132:1-5.
10. Gauthier A, Breuer J, Carrington D, Martin M, Remy V. 2009. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect 137:38-47.
11. Guess HA, Broughton DD, Melton LJ III, Kurland LT. 1985. Epidemiology of herpes zoster in children and adolescents: A population-based study. Pediatrics 76:512-517.
12. Heymann AD, Chodick G, Karpati T, Kamer L, Kremer E, Green MS, Kokia E, Shalev V. 2008. Diabetes as a risk factor for herpes zoster infection: Results of a population-based study in Israel. Infection 36:226-230.
13. Hope-Simpson RE. 1965. The nature of herpes zoster: A long-term study and a new hypothesis. Proc R Soc Med 58:9-20.
14. Kamiya H, Ihara T, Hattori A, Iwasa T, Sakurai M, Izawa T, Yamada A, Takahashi M. 1977. Diagnostic skin test reactions with varicella virus antigen and clinical application of the test. J Infect Dis 136:784-788. (Pubitemid 8245901)
15. Lin F, Hadler JL. 2000. Epidemiology of primary varicella and herpes zoster hospitalizations: The pre-varicella vaccine era. J Infect Dis 181:1897-1905. (Pubitemid 30416150)
16. Nagasako EM, Johnson RW, Griffin DR, Elpern DJ, Dworkin RH. 2003. Geographic and racial aspects of herpes zoster. J Med Virol 70:S20-S23.
17. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann JW, Jr., Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh SS, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan IS, Wang WW, Annunziato PW, Silber JL. 2005. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352:2271-2284. (Pubitemid 40740551)
18. Ragozzino MW, Melton LJ III, Kurland LT, Chu CP, Perry HO. 1982. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) 61:310-316. (Pubitemid 12031812)
19. Rogues AM, Dupon M, Ladner J, Ragnaud JM, Pellegrin JL, Dabis F. 1993. Herpes zoster and human immunodeficiency virus infection: A cohort study of 101 coinfected patients. Groupe d'Epidemiologie clinique du SIDA en aquitaine. J Infect Dis 168:245.
20. Schmader K, George LK, Burchett BM, Hamilton JD, Pieper CF. 1998. Race and stress in the incidence of herpes zoster in older adults. J Am Geriatr Soc 46:973-977. (Pubitemid 28374075)
21. Shiraki K, Yamanishi K, Takahashi M. 1984. Biologic and immunologic characterization of the soluble skin-test antigen of varicella-zoster virus. J Infect Dis 149:501-504. (Pubitemid 14139031)
22. Takahashi M, Kamiya H, Asano Y, Shiraki K, Baba K, Otsuka T, Hirota T, Yamanishi K. 2001. Immunization of the elderly to boost immunity against varicella-zoster virus (VZV) as assessed by VZV skin test reaction. Arch Virol 161-172. (Pubitemid 33760028)
23. Takahashi M, Okada S, Miyagawa H, Amo K, Yoshikawa K, Asada H, Kamiya H, Torigoe S, Asano Y, Ozaki T, Terada K, Muraki R, Higa K, Iwasaki H, Akiyama M, Takamizawa A, Shiraki K, Yanagi K, Yamanishi K. 2003. Enhancement of immunity against VZV by giving live varicella vaccine to the elderly assessed by VZV skin test and IAHA, gpELISA antibody assay. Vaccine 21:3845-3853. (Pubitemid 37338212)
24. Thomas SL, Hall AJ. 2004. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis 4:26-33.
25. Thomas SL, Wheeler JG, Hall AJ. 2002. Contacts with varicella or with children and protection against herpes zoster in adults: A case-control study. Lancet 360:678-682.
26. Yih WK, Brooks DR, Lett SM, Jumaan AO, Zhang Z, Clements KM, Seward JF. 2005. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003. BMC Public Health 5:68. (Pubitemid 41096318)